Furthermore, we found that NPRA-KO mice do not permit growth of implanted human lung cancer, melanoma and ovarian cancer cells [19], suggesting that NPRA may be a novel therapeutic candidate. This evidence concerns the gene NPR1 and ovarian cancer.